Filter News
Area of Research
News Topics
- (-) Biomedical (4)
- (-) Composites (2)
- (-) Cybersecurity (1)
- 3-D Printing/Advanced Manufacturing (5)
- Artificial Intelligence (1)
- Bioenergy (6)
- Chemical Sciences (2)
- Climate Change (1)
- Computer Science (7)
- Coronavirus (3)
- Critical Materials (2)
- Energy Storage (5)
- Environment (5)
- Isotopes (4)
- Machine Learning (1)
- Materials (1)
- Materials Science (22)
- Microscopy (4)
- Molten Salt (1)
- Nanotechnology (13)
- National Security (1)
- Neutron Science (22)
- Physics (7)
- Polymers (2)
- Quantum Science (6)
- Summit (4)
- Sustainable Energy (6)
- Transportation (3)
Media Contacts
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
Researchers at the Department of Energy’s Oak Ridge National Laboratory have received five 2019 R&D 100 Awards, increasing the lab’s total to 221 since the award’s inception in 1963.
ORNL and The University of Toledo have entered into a memorandum of understanding for collaborative research.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
Scientists at the Department of Energy’s Oak Ridge National Laboratory have created a recipe for a renewable 3D printing feedstock that could spur a profitable new use for an intractable biorefinery byproduct: lignin.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.